| Name | Title | Contact Details |
|---|
AIT is a technology consulting firm designing solutions through our deep expertise and extensive partner network for evolving small and mid-market businesses.
GyPSii is a Warwick, RI-based company in the Software and Internet sector.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
An ai startup in stealth mode, disrupting the on-demand economy.
International Business Machines Corporation is an American multinational information technology company headquartered in Armonk, New York, with operations in over 170 countries.